Puridify, the developer of new bioprocessing purification technologies based on nanofibre nonwovens for industrial biomolecule manufacturing, has signed a new 18-month collaboration agreement with GlaxoSmithKline (GSK) to extend the evaluation of its FibroSelect purification technology.
Already have an account? Log In




